Bio-X Weight Loss Center (Austin)

Bio-X Weight Loss Center operates as a telehealth-focused medical weight loss and regenerative medicine practice serving patients throughout Texas, with clinical oversight from Luis Wilmot Jr., MPAS, PA-C. The Austin-based clinic structures its programs around FDA-approved GLP-1 receptor agonists and complementary peptide protocols designed to address metabolic dysfunction, age-related decline, and body composition challenges through evidence-based pharmacotherapy. Unlike traditional weight loss centers that rely primarily on dietary counseling, Bio-X integrates pharmaceutical-grade peptides with metabolic optimization strategies, allowing patients to access prescription therapies without requiring in-person clinic visits across the state of Texas.

The clinic's weight management protocols center on semaglutide and tirzepatide, both incretin mimetics that modulate insulin secretion and appetite regulation through distinct receptor pathways. Semaglutide functions as a GLP-1 receptor agonist, while tirzepatide activates both GLP-1 and GIP receptors, offering dual incretin activity for patients who require more aggressive metabolic intervention. Bio-X prescribes these medications as part of structured programs that include dosage titration schedules, nutritional guidance, and ongoing monitoring of weight trends and metabolic markers. The clinic also incorporates NAD+ (nicotinamide adenine dinucleotide) supplementation into its anti-aging and metabolic protocols, administered via IV infusion for patients seeking cellular energy support and mitochondrial function enhancement. NAD+ therapy at Bio-X is positioned as an adjunct to weight loss efforts, particularly for patients experiencing fatigue or metabolic slowdown during caloric restriction phases.

Luis Wilmot Jr. brings physician assistant training and certification to his role as the clinic's lead provider, holding a Master of Physician Assistant Studies degree and PA-C credentials. His clinical approach emphasizes individualized peptide selection based on patient metabolic profiles, weight loss history, and concurrent health conditions such as insulin resistance or hormonal imbalances. Wilmot conducts telehealth consultations that include review of recent laboratory work, assessment of contraindications for GLP-1 therapies, and discussion of realistic weight loss timelines based on starting BMI and medication response patterns. The clinic's hormone optimization services address testosterone deficiency, thyroid dysfunction, and estrogen imbalance as contributing factors to weight gain and metabolic stagnation, with Wilmot coordinating peptide therapy alongside bioidentical hormone replacement when clinically indicated.

Patients initiating care at Bio-X Weight Loss Center complete an online intake process that includes medical history documentation, current medication review, and submission of recent lab results if available. The initial telehealth consultation with Wilmot covers weight loss goals, previous diet attempts, medication tolerance concerns, and screening for conditions that may contraindicate GLP-1 use such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Following the consultation, prescriptions are transmitted to partnered pharmacies, and patients receive detailed injection instructions for self-administration of semaglutide or tirzepatide at home. Follow-up appointments occur at regular intervals to assess weight trends, adjust dosing, manage side effects such as nausea or gastrointestinal changes, and determine appropriate duration of therapy. The clinic's IV therapy services, including NAD+ infusions, require coordination for in-person administration at the Austin location, though the majority of patient interactions occur through the telehealth platform.

Bio-X Weight Loss Center differentiates itself through its Texas-wide telehealth accessibility, eliminating geographic barriers for patients in rural areas or those with scheduling constraints that prevent regular clinic visits. The practice maintains a focused scope limited to weight management, metabolic optimization, and anti-aging interventions rather than attempting to serve as a comprehensive primary care provider. This specialization allows for deeper expertise in peptide pharmacology and weight loss medication management compared to general wellness clinics. Wilmot's PA training provides the clinical foundation for prescribing and monitoring controlled peptide therapies while maintaining collaborative relationships with patients' primary care physicians for management of underlying conditions such as diabetes or cardiovascular disease. The clinic's single five-star Google review reflects limited public feedback volume, typical for newer telehealth practices, though the rating indicates early patient satisfaction with the consultation process and treatment accessibility. For Austin-area residents and Texas patients seeking medical weight loss solutions beyond traditional diet programs, Bio-X offers prescription peptide access through a streamlined telehealth model with oversight from a credentialed physician assistant specializing in metabolic medicine.